Neurimmune AG

Neurimmune is a biopharmaceutical company translating human immune memory into antibody therapeutics. Neurimmune's Reverse Translational Medicine technology platform translates the genetic information from human white blood cells into selective high-affinity antibody drug candidates. Neurimmune’s pipeline comprises drug candidates for Alzheimer’s disease, amyotrophic lateral sclerosis, fronto-temporal dementia as well as cardiomyopathy and type 2 diabetes. Show more Show less